Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 010441

Expand all

RESERPINE (RESERPINE)
0.1MG
Marketing Status: Discontinued

Active Ingredient: RESERPINE
Proprietary Name: RESERPINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.1MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N010441
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: EVERYLIFE
Marketing Status:  Discontinued
Patent and Exclusivity Information

RESERPINE (RESERPINE)
0.25MG
Marketing Status: Discontinued

Active Ingredient: RESERPINE
Proprietary Name: RESERPINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.25MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N010441
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: EVERYLIFE
Marketing Status:  Discontinued
Patent and Exclusivity Information

RESERPINE (RESERPINE)
0.5MG
Marketing Status: Discontinued

Active Ingredient: RESERPINE
Proprietary Name: RESERPINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N010441
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: EVERYLIFE
Marketing Status:  Discontinued
Patent and Exclusivity Information

RESERPINE (RESERPINE)
1MG
Marketing Status: Discontinued

Active Ingredient: RESERPINE
Proprietary Name: RESERPINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 1MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N010441
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: EVERYLIFE
Marketing Status:  Discontinued
Patent and Exclusivity Information